If you take warfarin, aspirin, clopidogrel, or a DOAC and you're wondering whether it's safe to add a fish oil or omega-3 supplement, the short answer is: probably, but it's genuinely worth a conversation with your doctor or pharmacist first — not because omega-3 is dangerous, but because it does have a real, mild blood-thinning effect of its own, and stacking two things that affect clotting is exactly the kind of situation clinicians like to know about.
This isn't a myth to wave away, and it isn't a reason to panic either. Omega-3 fatty acids (EPA and DHA, the kind found in fish oil) modestly reduce platelet aggregation — the first step in clot formation. At typical supplement doses, most of the clinical evidence says this effect is small and rarely causes problems on its own. But "rarely" isn't "never," and the calculus changes somewhat at higher doses, in people already on strong anticoagulants, and around surgery or dental work, when even a small nudge in clotting time matters more.
Below is what the actual research shows — not the alarmist version, and not the dismissive version.
Does fish oil actually thin the blood?
Yes, to a degree. EPA and DHA get incorporated into cell membranes, including platelets, and shift the balance of eicosanoids your body produces toward less "sticky" ones. The practical effect is a mild reduction in platelet aggregation — the National Institutes of Health's Office of Dietary Supplements (ODS) fact sheet on omega-3 fatty acids states plainly that "fish oil can have antiplatelet effects at high doses, although it appears to be less potent than aspirin."1
So the mechanism is real. The question is whether that mild effect meaningfully adds to the bleeding risk of someone already taking a medication designed to reduce clotting.
If you're trying to work out what dose you actually need before you work out whether it's safe to combine, the two questions are best taken in that order — the omega-3 dosage guide covers EPA and DHA amounts and what the research supports.
What happens when you combine it with warfarin, aspirin, or clopidogrel
Warfarin is a vitamin K antagonist that's monitored via INR (international normalized ratio) — a blood test that tracks how long it takes blood to clot. Because fish oil can theoretically shift that number, the ODS fact sheet notes that "fish oil might prolong clotting times, as indicated by an elevated INR, when it is taken with warfarin," and recommends that "patients taking these products with anticoagulants should be monitored periodically for changes in INR."1 That's a real, documented interaction — which is exactly why it belongs in a conversation with whoever manages your warfarin dosing, not something to quietly self-manage.
At the same time, the same fact sheet is reassuring about typical doses: "most research indicates that doses of 3–6 g/day fish oil do not significantly affect the anticoagulant status of patients taking warfarin," and it notes that FDA-approved package inserts for prescription omega-3 medications state that studies "have not produced clinically significant bleeding episodes."1 The controlled evidence points the same way, and it is worth setting out rather than summarising as an interaction rating. A randomised, double-blind, placebo-controlled trial gave patients already stable on long-term warfarin either placebo, 3g or 6g of fish oil daily for four weeks after a four-week placebo run-in, and found no significant change in INR within groups (p=0.82) or between them (p=0.41), with one bruising episode and no major bleeds — though only eleven patients completed the randomised phase, so it is a small study.4 A larger retrospective analysis of 573 long-term warfarin patients, 145 of them taking fish or krill oil, found no significant difference in time spent in therapeutic range or in bleeding incidence.5 And two Phase I studies tested it formally: 4g daily of omega-3 carboxylic acids alongside warfarin produced no pharmacokinetic or INR interaction by the standard 80–125% bioequivalence criterion, and alongside 81mg aspirin produced no measurable effect on platelet activation.6
The counterweight is case reports rather than trials. The most-cited is a woman stable on warfarin for five months whose INR rose from 2.8 to 4.3 within a month of doubling her fish oil from 1000 to 2000mg daily, and fell to 1.6 a week after she reduced it again.7 So the honest read is: at typical doses the controlled data shows no meaningful interaction, the documented problems cluster around higher doses, dose changes, and people already taking aspirin or another antiplatelet — and a conversation with your prescriber before you start, or before you change the dose, is the sensible move rather than avoiding it outright.
Aspirin and clopidogrel (Plavix) work on platelets rather than clotting factors, which is the same system omega-3 nudges. In theory that's an additive effect, and it's part of why clinicians ask about supplement use when someone is on dual antiplatelet therapy. In practice, the largest and most recent evidence on real-world bleeding outcomes is more reassuring than the theory alone would suggest — see the meta-analysis below.
What the larger studies actually found
A 2024 systematic review and meta-analysis published in the Journal of the American Heart Association pooled data from 11 randomized controlled trials and more than 120,000 participants specifically to answer this question. It found no significant increase in overall bleeding events among people taking omega-3 PUFAs, and — importantly for this topic — no meaningful relationship between bleeding events and background use of antiplatelet medications. The one caveat: a small, non-clinically-significant increase (about 0.6%) appeared specifically in the highest-dose EPA trials, distinct from typical over-the-counter supplement doses.2
Surgical settings are where the "does it thin your blood too much" question gets tested most directly, since bleeding is easy to measure. In the OPERA trial, more than 1,500 patients undergoing cardiac surgery were given high-dose perioperative fish oil (6.5–8 g in the days before surgery, then 1.7 g daily through discharge) — doses well above a typical daily supplement. The result: fish oil did not increase perioperative bleeding, and patients with higher blood EPA/DHA levels on the morning of surgery actually needed fewer blood transfusion units, not more.3 That's one well-designed trial in one surgical population, not a blanket "fish oil is fine before any operation" conclusion — but it does show the real-world signal is weaker than the mechanism alone would predict.
Omega-3's antiplatelet effect is real and measurable — but at typical supplement doses, the large trials haven't found it adds up to a meaningfully higher bleeding risk on top of standard blood thinners.
Bleeding is not the only reason the cardiovascular evidence is worth reading carefully — two of the major reviews of omega-3 and heart health reached genuinely different conclusions, which we've set out in omega-3 and heart health: two major reviews, two different conclusions.
Where caution still matters: surgery and dental procedures
Even with reassuring large-trial data, clinicians commonly advise stopping high-dose fish oil before elective surgery or invasive dental work — typically alongside other agents that affect platelets, such as aspirin or NSAIDs. This is a "why take an unnecessary variable into an already-monitored situation" precaution rather than proof of harm at normal doses, and it's precisely the kind of judgment call that depends on your specific medications, the procedure, and your surgeon or dentist's protocol. If you have a procedure coming up and take both a blood thinner and an omega-3 supplement, ask your surgical or dental team directly whether and when to pause it — don't guess.
Anticoagulants are not the only medication class worth raising. Magnesium has its own set of interactions, mostly solved by timing — see does magnesium interact with any medications? — and if you take psychiatric medication, Proco products and mental health medications covers that separately. Combining more than one product from the range is its own question: is it safe to take multiple Proco products together?
A quick reference by medication type
| Medication type | Examples | What to know |
|---|---|---|
| Vitamin K antagonist | Warfarin | Monitored via INR. Most research finds 3–6 g/day of fish oil (roughly 1–2 g/day EPA+DHA) does not significantly change anticoagulant status, but periodic INR monitoring is still advised — and the NIH notes fish oil might prolong clotting times with warfarin. |
| Antiplatelets | Aspirin, clopidogrel | Same general system (platelet function) as omega-3's mild effect; large pooled data hasn't shown a meaningful added bleeding signal at typical doses. |
| DOACs | Apixaban, rivaroxaban, dabigatran, edoxaban | Less omega-3-specific interaction data exists than for warfarin; general bleeding-risk caution still applies, especially at higher fish-oil doses. |
| Any of the above + upcoming surgery/dental work | — | Ask your surgeon, dentist, or pharmacist whether and when to pause fish oil beforehand — protocols vary by procedure and provider. |
What this means for how much you take
This is the part most write-ups get muddled, and the muddle points in the unsafe direction, so it's worth being pedantic. Grams of fish oil and grams of EPA+DHA are not the same number. The NIH's reassuring statement is about 3–6 g/day of fish oil — which, at typical concentrations, is somewhere around 1–2 g/day of actual EPA+DHA. The prescription-strength range that the bleeding signal attaches to is 4 g/day of purified EPA or EPA/DHA, several times higher in active terms. And OPERA's pre-surgical loading was higher again.
For scale at the other end: US adults average roughly 90 mg a day of EPA+DHA from food. Proco's Omega-3 is one softgel providing 1,000 mg of fish oil, of which 180 mg is EPA and 120 mg DHA — 300 mg of EPA+DHA per softgel. That is an order of magnitude below the prescription doses where the bleeding signal shows up, and well below even the 3–6 g/day fish-oil range the NIH statement covers. None of which makes the conversation with your doctor optional: bring the exact numbers off the label — fish oil mass and EPA+DHA mass separately — rather than "I take a fish oil pill." If you take a high-concentrate product, several grams a day of purified EPA is a materially different conversation from a single 1,000 mg softgel, and your prescriber cannot tell which you mean without the figures.
Bottom line
The interaction between fish oil and blood thinners is real, biologically plausible, and worth taking seriously — but the best available evidence, including a 120,000-plus-patient meta-analysis and a dedicated cardiac-surgery trial, suggests the added bleeding risk at ordinary supplement doses — hundreds of milligrams of EPA+DHA rather than several grams of purified EPA — is small. That combination of "real but usually small" is exactly why this is a talk-to-your-doctor situation rather than either a "don't worry about it" or a "never combine these" one.
This article is for informational purposes only and has not been evaluated by the FDA. It is not intended to diagnose, treat, cure, or prevent any disease. If you take a blood thinner or anticoagulant medication (including warfarin, aspirin, clopidogrel, or a DOAC), talk to your doctor or pharmacist before starting omega-3 or fish oil supplementation, and before any surgery or dental procedure.
References
- National Institutes of Health, Office of Dietary Supplements. "Omega-3 Fatty Acids — Health Professional Fact Sheet." ods.od.nih.gov
- "Bleeding Risk in Patients Receiving Omega-3 Polyunsaturated Fatty Acids: A Systematic Review and Meta-Analysis of Randomized Clinical Trials." Journal of the American Heart Association, 2024. pubmed.ncbi.nlm.nih.gov
- "Fish Oil and Perioperative Bleeding: Insights From the OPERA Trial." Circulation: Cardiovascular Quality and Outcomes, 2018. ahajournals.org
- Bender NK, Kraynak MA, Chiquette E, Linn WD, Clark GM, Bussey HI. Effects of marine fish oils on the anticoagulation status of patients receiving chronic warfarin therapy. J Thromb Thrombolysis. 1998. doi:10.1023/a:1008852127668
- Pryce R, Bernaitis N, Davey AK, Badrick T, Anoopkumar-Dukie S. The use of fish oil with warfarin does not significantly affect either the international normalised ratio or incidence of adverse events in patients with atrial fibrillation and deep vein thrombosis: a retrospective study. Nutrients. 2016. doi:10.3390/nu8090578
- Offman E, Davidson M, Nilsson C. No effect of omega-3 carboxylic acids on pharmacokinetics/pharmacodynamics of warfarin or on platelet function when co-administered with acetylsalicylic acid: results of two phase I studies in healthy volunteers. Am J Cardiovasc Drugs. 2017. doi:10.1007/s40256-017-0217-4
- Buckley MS, Goff AD, Knapp WE. Fish oil interaction with warfarin. Ann Pharmacother. 2004. doi:10.1345/aph.1d007
Related reading: Omega-3 EPA/DHA Dosage Guide and Omega-3 and Heart Health: Two Reviews, Two Conclusions.
Want to know what's actually in what you take? Join the list — no spam, just it straight.